C17orf37 antibody
Quick Overview for C17orf37 antibody (ABIN7073498)
Target
See all C17orf37 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Rat
-
Purification
- Affinity purification
-
Immunogen
- Recombinant protein corresponding to Mouse XTP4
-
-
-
-
Application Notes
- WB (M,R) 1:200-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- C17orf37 (Chromosome 17 Open Reading Frame 37 (C17orf37))
-
Alternative Name
- XTP4
-
Background
- During the past decade, the role of the ERBB2(neu/HER2) oncogene as an important predictor of patient outcome and response to various therapies in breast cancer has been clearly established. The C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Identification of shared tumor-specific targets is useful in developing broadly applicable therapies. The C35 gene is located on chromosome 17q12, 505nucleotides from the 3' end of the ERBB2oncogene, the antigenic target for trastuzumab(Herceptin) therapy. The chromosomal arrangement of the genes encoding C35 andERBB2 is tail to tail.
-
Molecular Weight
- 12 kDa
-
Gene ID
- 103742
-
NCBI Accession
- NP_079835
-
UniProt
- Q9CQ86
-
Pathways
- Cell RedoxHomeostasis
Target
-